The Healgen® COVID-19/Flu A&B Test Kit Named One of 2024's Top 5 Medical Breakthroughs by ABC News
Date: January 14,2025
Healgen® is proud to be acknowledged as part of this select group of groundbreaking discoveries and is deeply committed to delivering innovative and accessible healthcare solutions that truly make a difference in people’s lives. Read the full story from ABC News.

The Healgen® COVID-19/Flu A&B Antigen Test Kit is the first over-the-counter, at-home diagnostic tool to receive De Novo authorization from the U.S. Food and Drug Administration (FDA) for detecting both SARS-CoV-2 and Influenza A/B. Learn more about this news. This milestone is a testament to our dedication to advancing in vitro diagnostics for improved public health.

Key Features and Benefits:

●      Dual Detection: Simultaneously identifies COVID-19, Influenza A, and Influenza B, helping users quickly determine the cause of their symptoms.

●      Fast Results: Provides reliable results within just 15 minutes, enabling prompt decision-making.

●      Easy Sampling: Utilizes a shallow nasal swab that is comfortable and suitable for individuals aged 2 and older.

●      Exceptional Accuracy:

○      COVID-19 Sensitivity: 99.1%

○      Influenza A Sensitivity: 99.9%

○      Influenza B Sensitivity: 100%

●      No Serial Testing Required: Unlike other at-home tests, accurate results are given without the need for repeat testing.

Thank You for Your Support! We extend our deepest gratitude to our partners and distributors for your continued trust and support. Together, we are revolutionizing diagnostics and making healthcare more accessible worldwide.

Learn More:

To find out more about this award-winning test kit and other Healgen® products:

●      Visit our website.

●      Follow us on our social media channels for the latest updates.

-        Facebook

       LinkedIn

Let’s continue to innovate and improve healthcare solutions together!

Share: